tepotinib
Sign in to saveAlso known as compound 22 [PMID: 25736998], EMD 1214063, EMD-1214063, MSC2156119, MSC2156119J
Tepotinib, sold under the brand name Tepmetko, is an anti-cancer medication used for the treatment of adults with non-small cell lung cancer (NSCLC).
Wikidata facts
- Mass
- 492.227
Show 3 more facts
- chemical formula
- C₂₉H₂₈N₆O₂
- canonical SMILES
- CN1CCC(CC1)COC2=CN=C(N=C2)C3=CC(=CC=C3)CN4C(=O)C=CC(=N4)C5=CC=CC(=C5)C#N
- Commons category
- Tepotinib
Sources (2)
via Wikidata · CC0
~5 min read
Article
7 sectionsContents
- Medical uses
- Adverse effects
- Society and culture
- Legal status
- References
- Further reading
- External links
{{Infobox drug | image = Tepotinib.svg | image_class = skin-invert-image | width = | alt = | caption = | image2 = Tepotinib ball-and-stick 4R1V.png | image_class2 = bg-transparent | alt2 =
| pronounce = | tradename = Tepmetko | Drugs.com = | MedlinePlus = a621012 | DailyMedID = Tepotinib | pregnancy_AU = D | pregnancy_AU_comment = | pregnancy_category= Not recommended | routes_of_administration = By mouth | class = | ATC_prefix = L01 | ATC_suffix = EP02 | ATC_supplemental =